Cargando…
Mass spectrometric analysis of chondroitin sulfate-linked peptides
Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526814/ https://www.ncbi.nlm.nih.gov/pubmed/36213313 http://dx.doi.org/10.1007/s42485-022-00092-3 |
_version_ | 1784800960127696896 |
---|---|
author | Ramarajan, Madan Gopal Saraswat, Mayank Budhraja, Rohit Garapati, Kishore Raymond, Kimiyo Pandey, Akhilesh |
author_facet | Ramarajan, Madan Gopal Saraswat, Mayank Budhraja, Rohit Garapati, Kishore Raymond, Kimiyo Pandey, Akhilesh |
author_sort | Ramarajan, Madan Gopal |
collection | PubMed |
description | Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through interaction with growth factors and signaling proteins. These pleiotropic functions of proteoglycans are regulated spatiotemporally by the GAG chains attached to the core protein. There are over 70 chondroitin sulfate-linked proteoglycans reported in cells, cerebrospinal fluid and urine. A core glycan linker of 3–6 monosaccharides attached to specific serine residues can be extended by 20–200 disaccharide repeating units making intact CSPGs very large and impractical to analyze. The current paradigm of CSPG analysis involves digesting the GAG chains by chondroitinase enzymes and analyzing either the protein part, the disaccharide repeats, or both by mass spectrometry. This method, however, provides no information about the site of attachment or the composition of linker oligosaccharides and the degree of sulfation and/or phosphorylation. Further, the analysis by mass spectrometry and subsequent identification of novel CSPGs is hampered by technical challenges in their isolation, less optimal ionization and data analysis. Unknown identity of the linker oligosaccharide also makes it more difficult to identify the glycan composition using database searching approaches. Following chondroitinase digestion of long GAG chains linked to tryptic peptides, we identified intact GAG-linked peptides in clinically relevant samples including plasma, urine and dermal fibroblasts. These intact glycopeptides including their core linker glycans were identified by mass spectrometry using optimized stepped higher energy collision dissociation and electron-transfer/higher energy collision dissociation combined with hybrid database search/de novo glycan composition search. We identified 25 CSPGs including three novel CSPGs that have not been described earlier. Our findings demonstrate the utility of combining enrichment strategies and optimized high-resolution mass spectrometry analysis including alternative fragmentation methods for the characterization of CSPGs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42485-022-00092-3. |
format | Online Article Text |
id | pubmed-9526814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-95268142022-10-03 Mass spectrometric analysis of chondroitin sulfate-linked peptides Ramarajan, Madan Gopal Saraswat, Mayank Budhraja, Rohit Garapati, Kishore Raymond, Kimiyo Pandey, Akhilesh J Proteins Proteom Original Article Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through interaction with growth factors and signaling proteins. These pleiotropic functions of proteoglycans are regulated spatiotemporally by the GAG chains attached to the core protein. There are over 70 chondroitin sulfate-linked proteoglycans reported in cells, cerebrospinal fluid and urine. A core glycan linker of 3–6 monosaccharides attached to specific serine residues can be extended by 20–200 disaccharide repeating units making intact CSPGs very large and impractical to analyze. The current paradigm of CSPG analysis involves digesting the GAG chains by chondroitinase enzymes and analyzing either the protein part, the disaccharide repeats, or both by mass spectrometry. This method, however, provides no information about the site of attachment or the composition of linker oligosaccharides and the degree of sulfation and/or phosphorylation. Further, the analysis by mass spectrometry and subsequent identification of novel CSPGs is hampered by technical challenges in their isolation, less optimal ionization and data analysis. Unknown identity of the linker oligosaccharide also makes it more difficult to identify the glycan composition using database searching approaches. Following chondroitinase digestion of long GAG chains linked to tryptic peptides, we identified intact GAG-linked peptides in clinically relevant samples including plasma, urine and dermal fibroblasts. These intact glycopeptides including their core linker glycans were identified by mass spectrometry using optimized stepped higher energy collision dissociation and electron-transfer/higher energy collision dissociation combined with hybrid database search/de novo glycan composition search. We identified 25 CSPGs including three novel CSPGs that have not been described earlier. Our findings demonstrate the utility of combining enrichment strategies and optimized high-resolution mass spectrometry analysis including alternative fragmentation methods for the characterization of CSPGs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42485-022-00092-3. Springer Nature Singapore 2022-10-02 2022 /pmc/articles/PMC9526814/ /pubmed/36213313 http://dx.doi.org/10.1007/s42485-022-00092-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Ramarajan, Madan Gopal Saraswat, Mayank Budhraja, Rohit Garapati, Kishore Raymond, Kimiyo Pandey, Akhilesh Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title | Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title_full | Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title_fullStr | Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title_full_unstemmed | Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title_short | Mass spectrometric analysis of chondroitin sulfate-linked peptides |
title_sort | mass spectrometric analysis of chondroitin sulfate-linked peptides |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526814/ https://www.ncbi.nlm.nih.gov/pubmed/36213313 http://dx.doi.org/10.1007/s42485-022-00092-3 |
work_keys_str_mv | AT ramarajanmadangopal massspectrometricanalysisofchondroitinsulfatelinkedpeptides AT saraswatmayank massspectrometricanalysisofchondroitinsulfatelinkedpeptides AT budhrajarohit massspectrometricanalysisofchondroitinsulfatelinkedpeptides AT garapatikishore massspectrometricanalysisofchondroitinsulfatelinkedpeptides AT raymondkimiyo massspectrometricanalysisofchondroitinsulfatelinkedpeptides AT pandeyakhilesh massspectrometricanalysisofchondroitinsulfatelinkedpeptides |